Global Pharmatech Stock Market Value
| GBLP Stock | USD 0.05 0.00 0.00% |
| Symbol | Global |
Global Pharmatech 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Global Pharmatech's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Global Pharmatech.
| 11/27/2025 |
| 12/27/2025 |
If you would invest 0.00 in Global Pharmatech on November 27, 2025 and sell it all today you would earn a total of 0.00 from holding Global Pharmatech or generate 0.0% return on investment in Global Pharmatech over 30 days. Global Pharmatech is related to or competes with Charlottes Web, Avicanna, and Raphael Pharmaceutical. Global Pharmatech, Inc. engages in the research, production, and development of herbal medicine, bio-medicine, chemical ... More
Global Pharmatech Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Global Pharmatech's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Global Pharmatech upside and downside potential and time the market with a certain degree of confidence.
Global Pharmatech Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Global Pharmatech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Global Pharmatech's standard deviation. In reality, there are many statistical measures that can use Global Pharmatech historical prices to predict the future Global Pharmatech's volatility.Global Pharmatech Backtested Returns
We have found three technical indicators for Global Pharmatech, which you can use to evaluate the volatility of the firm. The company retains a Market Volatility (i.e., Beta) of 0.0, which attests to not very significant fluctuations relative to the market. the returns on MARKET and Global Pharmatech are completely uncorrelated.
Auto-correlation | 1.00 |
Perfect predictability
Global Pharmatech has perfect predictability. Overlapping area represents the amount of predictability between Global Pharmatech time series from 27th of November 2025 to 12th of December 2025 and 12th of December 2025 to 27th of December 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Global Pharmatech price movement. The serial correlation of 1.0 indicates that 100.0% of current Global Pharmatech price fluctuation can be explain by its past prices.
| Correlation Coefficient | 1.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Global Pharmatech lagged returns against current returns
Autocorrelation, which is Global Pharmatech pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Global Pharmatech's pink sheet expected returns. We can calculate the autocorrelation of Global Pharmatech returns to help us make a trade decision. For example, suppose you find that Global Pharmatech has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Global Pharmatech regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Global Pharmatech pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Global Pharmatech pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Global Pharmatech pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Global Pharmatech Lagged Returns
When evaluating Global Pharmatech's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Global Pharmatech pink sheet have on its future price. Global Pharmatech autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Global Pharmatech autocorrelation shows the relationship between Global Pharmatech pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Global Pharmatech.
Regressed Prices |
| Timeline |
Pair Trading with Global Pharmatech
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Global Pharmatech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Global Pharmatech will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Global Pharmatech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Global Pharmatech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Global Pharmatech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Global Pharmatech to buy it.
The correlation of Global Pharmatech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Global Pharmatech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Global Pharmatech moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Global Pharmatech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Global Pink Sheet Analysis
When running Global Pharmatech's price analysis, check to measure Global Pharmatech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Global Pharmatech is operating at the current time. Most of Global Pharmatech's value examination focuses on studying past and present price action to predict the probability of Global Pharmatech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Global Pharmatech's price. Additionally, you may evaluate how the addition of Global Pharmatech to your portfolios can decrease your overall portfolio volatility.